Estée Lauder confirms merger discussions with Spain's Puig, potentially creating a $40 billion beauty conglomerate, as shares tumble 7.72% on dilution concerns while the company struggles with tariff-related profitability pressures and ongoing restructuring efforts.
#YonhapInfomax #EstéeLauder #Puig #MergerTalks #BeautyIndustry #SharePriceDrop #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=111647
Estée Lauder Shares Fall 7% on Merger Talks with Spain's Puig
Estée Lauder confirms merger discussions with Spain's Puig, potentially creating a $40 billion beauty conglomerate, as shares tumble 7.72% on dilution concerns while the company struggles with tariff-related profitability pressures and ongoing restructuring efforts.
Nvidia's Q4 earnings surpassed expectations, but shares fell over 5% as Wall Street analysts say investor expectations for AI leaders like Nvidia are rising, making strong results alone insufficient to boost the stock.
#YonhapInfomax #Nvidia #Earnings #WallStreet #ArtificialIntelligence #SharePriceDrop #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=107184
Wall Street Says 'Nvidia's Strong Earnings Raise the Bar for Market Expectations'
Nvidia's Q4 earnings surpassed expectations, but shares fell over 5% as Wall Street analysts say investor expectations for AI leaders like Nvidia are rising, making strong results alone insufficient to boost the stock.
C3 AI Shares Plunge on Workforce Reduction and Disappointing Earnings
C3 AI shares tumbled after the company announced a 26% global workforce reduction and reported quarterly revenue and earnings that fell far short of market expectations.
Lowe's Annual Guidance Misses Expectations—Shares Fall 3%
Lowe's Companies Inc. reported strong Q4 results but issued annual guidance below market expectations, causing shares to fall over 3% as investors reacted to the outlook.
Blue Owl Capital clarified that suspending quarterly redemptions for its OBDC II fund does not block investor liquidity, after the move triggered a 10% share price drop amid rising redemption requests and AI sector volatility.
#YonhapInfomax #BlueOwlCapital #OBDCII #Redemption #AIBubble #SharePriceDrop #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=105939
Blue Owl Moves to Clarify—'Not Blocking Investor Access to Liquidity'
Blue Owl Capital clarified that suspending quarterly redemptions for its OBDC II fund does not block investor liquidity, after the move triggered a 10% share price drop amid rising redemption requests and AI sector volatility.
Walmart Shares Fall 3% as Full-Year Guidance Misses Expectations Despite Strong Q4 Results
Walmart Inc. reported stronger-than-expected Q4 earnings and revenue, but shares fell 3% as its full-year guidance missed analyst forecasts, raising investor concerns.
Moderna’s Flu Vaccine Review Rejected by FDA—Shares Plunge 8% After Hours
Moderna shares plunged 8% after the FDA refused to review its next-generation flu vaccine, citing clinical trial design issues rather than safety or efficacy concerns.
Coca-Cola Shares Fall After Q4 Earnings Release—Guidance Misses Expectations
Coca-Cola shares fell over 1% after Q4 results, as the beverage giant’s revenue and 2024 guidance missed market expectations despite EPS beating forecasts.
Block Inc., led by Jack Dorsey, will cut up to 10% of its workforce by February, marking its third straight year of major layoffs amid weak share performance and earnings pressure.
#YonhapInfomax #BlockInc #JackDorsey #Layoffs #Earnings #SharePriceDrop #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=104736
Block, Led by Jack Dorsey, Announces Another 10% Workforce Reduction—Third Consecutive Year of Layoffs
Block Inc., led by Jack Dorsey, will cut up to 10% of its workforce by February, marking its third straight year of major layoffs amid weak share performance and earnings pressure.
Hims & Hers shares plunged over 16% after Novo Nordisk sued the telehealth firm for allegedly selling unauthorized generic versions of obesity drug Wegovy, intensifying legal risks in the US obesity drug market.
#YonhapInfomax #HimsAndHers #NovoNordisk #Wegovy #PatentInfringement #SharePriceDrop #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=104655
Yonhap Infomax News